158 related articles for article (PubMed ID: 36896021)
1. Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy.
Hoefges A; McIlwain SJ; Erbe AK; Mathers N; Xu A; Melby D; Tetreault K; Le T; Kim K; Pinapati RS; Garcia B; Patel J; Heck M; Feils AS; Tsarovsky N; Hank JA; Morris ZS; Ong IM; Sondel PM
bioRxiv; 2023 Apr; ():. PubMed ID: 36896021
[TBL] [Abstract][Full Text] [Related]
2. Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen.
Hoefges A; McIlwain SJ; Erbe AK; Mathers N; Xu A; Melby D; Tetreault K; Le T; Kim K; Pinapati RS; Garcia BH; Patel J; Heck M; Feils AS; Tsarovsky N; Hank JA; Morris ZS; Ong IM; Sondel PM
Front Immunol; 2023; 14():1221155. PubMed ID: 38077403
[TBL] [Abstract][Full Text] [Related]
3.
Baniel CC; Heinze CM; Hoefges A; Sumiec EG; Hank JA; Carlson PM; Jin WJ; Patel RB; Sriramaneni RN; Gillies SD; Erbe AK; Schwarz CN; Pieper AA; Rakhmilevich AL; Sondel PM; Morris ZS
Front Immunol; 2020; 11():1610. PubMed ID: 32849544
[TBL] [Abstract][Full Text] [Related]
4. In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases.
Clark PA; Sriramaneni RN; Jin WJ; Jagodinsky JC; Bates AM; Jaquish AA; Anderson BR; Le T; Lubin JA; Chakravarty I; Arthur IS; Heinze CM; Guy EI; Kler J; Klar KA; Carlson PM; Kim KM; Kuo JS; Morris ZS
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690669
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model.
Baniel CC; Sumiec EG; Hank JA; Bates AM; Erbe AK; Pieper AA; Hoefges AG; Patel RB; Rakhmilevich AL; Morris ZS; Sondel PM
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115944
[TBL] [Abstract][Full Text] [Related]
6. Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.
Carlson PM; Patel RB; Birstler J; Rodriquez M; Sun C; Erbe AK; Bates AM; Marsh I; Grudzinski J; Hernandez R; Pieper AA; Feils AS; Rakhmilevich AL; Weichert JP; Bednarz BP; Sondel PM; Morris ZS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36639155
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model.
Ruf P; Schäfer B; Eissler N; Mocikat R; Hess J; Plöscher M; Wosch S; Suckstorff I; Zehetmeier C; Lindhofer H
J Transl Med; 2012 Nov; 10():219. PubMed ID: 23134699
[TBL] [Abstract][Full Text] [Related]
8. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
Murata K; Nakatsugawa M; Rahman MA; Nguyen LT; Millar DG; Mulder DT; Sugata K; Saijo H; Matsunaga Y; Kagoya Y; Guo T; Anczurowski M; Wang CH; Burt BD; Ly D; Saso K; Easson A; Goldstein DP; Reedijk M; Ghazarian D; Pugh TJ; Butler MO; Mak TW; Ohashi PS; Hirano N
Elife; 2020 Apr; 9():. PubMed ID: 32314731
[TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain.
Clark PA; Sriramaneni RN; Bates AM; Jin WJ; Jagodinsky JC; Hernandez R; Le T; Jeffery JJ; Marsh IR; Grudzinski JJ; Aluicio-Sarduy E; Barnhart TE; Anderson BR; Chakravarty I; Arthur IS; Kim K; Engle JW; Bednarz BP; Weichert JP; Morris ZS
Radiat Res; 2021 Jun; 195(6):522-540. PubMed ID: 33826741
[TBL] [Abstract][Full Text] [Related]
11. CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice.
Switaj T; Jalili A; Jakubowska AB; Drela N; Stoksik M; Nowis D; Basak G; Golab J; Wysocki PJ; Mackiewicz A; Sasor A; Socha K; Jakóbisiak M; Lasek W
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4165-75. PubMed ID: 15217954
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody Landscape in Patients with Advanced Prostate Cancer.
Chen WS; Haynes WA; Waitz R; Kamath K; Vega-Crespo A; Shrestha R; Zhang M; Foye A; Baselga Carretero I; Perez Garcilazo I; Zhang M; Zhao SG; Sjöström M; Quigley DA; Chou J; Beer TM; Rettig M; Gleave M; Evans CP; Lara P; Chi KN; Reiter RE; Alumkal JJ; Ashworth A; Aggarwal R; Small EJ; Daugherty PS; Ribas A; Oh DY; Shon JC; Feng FY
Clin Cancer Res; 2020 Dec; 26(23):6204-6214. PubMed ID: 32967941
[TBL] [Abstract][Full Text] [Related]
13. A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.
Shi J; Jiao T; Guo Q; Weng W; Ma L; Zhang Q; Wang L; Zhang J; Chen C; Huang Y; Wang M; Pan R; Tang Y; Hu W; Meng T; Liu SH; Guo J; Kong Y; Meng X
Cancer Res; 2023 Nov; 83(22):3783-3795. PubMed ID: 37668527
[TBL] [Abstract][Full Text] [Related]
14. Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
Voeller J; Erbe AK; Slowinski J; Rasmussen K; Carlson PM; Hoefges A; VandenHeuvel S; Stuckwisch A; Wang X; Gillies SD; Patel RB; Farrel A; Rokita JL; Maris J; Hank JA; Morris ZS; Rakhmilevich AL; Sondel PM
J Immunother Cancer; 2019 Dec; 7(1):344. PubMed ID: 31810498
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma.
Xia Y; Wei J; Zhao S; Guo B; Meng F; Klumperman B; Zhong Z
J Control Release; 2021 Aug; 336():262-273. PubMed ID: 34174350
[TBL] [Abstract][Full Text] [Related]
16. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice.
Lasek W; Mackiewicz A; Czajka A; Switaj T; Goł b J; Wiznerowicz M; Korczak-Kowalska G; Bakowiec-Iskra EZ; Gryska K; Izycki D; Jakóbisiak M
Cancer Gene Ther; 2000 Dec; 7(12):1581-90. PubMed ID: 11228537
[TBL] [Abstract][Full Text] [Related]
18. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
Ravindranath MH; Morton DL; Irie RF
Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
[TBL] [Abstract][Full Text] [Related]
19. Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
Brentville VA; Symonds P; Chua J; Skinner A; Daniels I; Cook KW; Koncarevic S; Martinez-Pinna R; Shah S; Choudhury RH; Vaghela P; Weston D; Al-Omari A; Davis J; Durrant LG
Front Immunol; 2022; 13():1066185. PubMed ID: 36544781
[TBL] [Abstract][Full Text] [Related]
20. Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice.
Pieper AA; Rakhmilevich AL; Spiegelman DV; Patel RB; Birstler J; Jin WJ; Carlson PM; Charych DH; Hank JA; Erbe AK; Overwijk WW; Morris ZS; Sondel PM
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34172518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
